Bronchitis And Emphysema Inhaler Linked With Increased Mortality

Links shared publicly online about this topic.

218
total visits

Bronchitis And Emphysema Inhaler Linked With Increased Mortality

An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research by the University of East Anglia (UE

View full resource at medicalnewstoday.com

Tags: Breathing, Bronchitis, COPD, Emphysema, Mortality

Most Recently Shared on June 15, 2011 at 1:29 am By:

Drugs and Devices OW

Bronchitis And Emphysema Inhaler Linked With Increased Mortality: An inhaler designed to help chronic... http://bit.ly/mdkFcz #MedDevice

12 months ago...

Retweet

Favorite

Also Shared By:

Lungs and Breathing

Researchers: Tiotropium inhaler may raise mortality risk - Related Stories - ANA SmartBrief

smartbrief.com — “People who used a Spiriva Respimat inhaler to ease breathing problems linked to lung diseases such as chronic bronchitis and emphysema were 52% more likely to die compared with a placebo group, a 6,500-participant study published in the British Medical Journal found. Researchers estimated that ther…” View full resource at smartbrief.com

Most Recently Shared on June 15, 2011 at 1:50 pm By:

Carole Eldridge, DNP Doctor, Advanced Practice Nurse, DNP, and Nurse

Researchers: Tiotropium inhaler may raise mortality risk http://t.co/y0p4yNL

12 months ago...

Retweet

Favorite

Bronchitis and emphysema inhaler linked with increased mortality

sciencedaily.com — “An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research.” View full resource at sciencedaily.com